SCHEMBL6983097

SCHEMBL6983097

[O]CCc1cc(Cl)nc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
HTT P42858 2/20 0.45
USP2 O75604 1/20 0.45
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
KMT2A Q03164 5/20 0.42
MAPT P10636 6/20 0.41
IGF1R P08069 1/20 0.41
HPGD P15428 2/20 0.41
ALDH1A1 P00352 6/20 0.40
GAA P10253 3/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
POLB P06746 1/20 0.40
AHR P35869 1/20 0.39
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3972714 0.85 KDM4E (0.49) KDM4EHTTUSP2MAOAMAOB
SCHEMBL6983102 0.82 KDM4E (0.46) KDM4EHTTUSP2MAOAMAOB
SCHEMBL5910669 0.81 KDM4E (0.53) KDM4EHTTUSP2MAOAMAOB
SCHEMBL27529063 0.81 KDM4E (0.50) KDM4EHTTUSP2KMT2AMAPT
SCHEMBL30517871 0.81 KMT2A (0.53) KDM4EHTTUSP2MAOAMAOB
SCHEMBL11343689 0.81 KMT2A (0.53) KDM4EHTTUSP2MAOAMAOB
SCHEMBL3972718 0.79 KDM4E (0.50) KDM4EHTTUSP2MAOAMAOB
Hydrochloric Acid SCHEMBL6629225 0.79 KMT2A (0.52) KDM4EHTTUSP2MAOAMAOB
SCHEMBL7262454 0.79 KDM4E (0.40) KDM4EKMT2AHPGDALDH1A1GAA
SCHEMBL6964689 0.79 CYP1A2 (0.56) KDM4EHTTKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299379-A2 LACTAM METALLOPROTEASE INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-04-09 EP disclosed
WO-2002004416-A2 LACTAM METALLOPROTEASE INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-01-17 WO disclosed